Entering text into the input field will update the search result below

AbbVie (ABBV) Q3 2018 Results - Earnings Call Transcript

Nov. 02, 2018 12:22 PM ETAbbVie Inc. (ABBV)2 Comments
SA Transcripts profile picture
SA Transcripts

AbbVie, Inc. (NYSE:ABBV) Q3 2018 Earnings Call November 2, 2018 9:00 AM ET


Elizabeth Shea - AbbVie, Inc.

Richard A. Gonzalez - AbbVie, Inc.

Michael E. Severino - AbbVie, Inc.

William J. Chase - AbbVie, Inc.


Steve Scala - Cowen & Co. LLC

Jason M. Gerberry - Bank of America Merrill Lynch

Joshua Schimmer - Evercore ISI

Vamil K. Divan - Credit Suisse Securities (USA) LLC

Andrew S. Baum - Citigroup Global Markets Ltd.

Chris Schott - JPMorgan Securities LLC

David R. Risinger - Morgan Stanley & Co. LLC

John T. Boris - SunTrust Robinson Humphrey, Inc.


Good morning. Welcome to the AbbVie third quarter 2018 earnings conference call. All participants will be able to listen only until the question-and-answer portion of this call.

I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations.

Elizabeth Shea - AbbVie, Inc.

Good morning and thanks for joining us. Also on the call with me today are: Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Executive Vice President of Research and Development and Chief Scientific Officer; Bill Chase, Executive Vice President of Finance and Administration; and Rob Michael, Senior Vice President and Chief Financial Officer.

Before we get started, I would like to remind you that statements we make today are or may be considered forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Additional information about the factors that may affect AbbVie's operations is included in our 2017 Annual Report on Form 10-K and in our other SEC filings. AbbVie undertakes no obligation to release publicly any revisions to forward-looking statements as a result

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.